Cargando…
Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer
Ovarian cancer (OC) is one of the most intractable diseases, exhibiting tremendous molecular heterogeneity and lacking reliable methods for screening, resulting in late diagnosis and widespread peritoneal dissemination. Menopausal estrogen replacement therapy is a well‐recognized risk factor for OC,...
Autores principales: | Benhadjeba, Samira, Edjekouane, Lydia, Sauvé, Karine, Carmona, Euridice, Tremblay, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165996/ https://www.ncbi.nlm.nih.gov/pubmed/30051594 http://dx.doi.org/10.1002/1878-0261.12362 |
Ejemplares similares
-
Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells
por: Edjekouane, Lydia, et al.
Publicado: (2016) -
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020) -
Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer
por: Yoffou, Paule Héléna, et al.
Publicado: (2011) -
The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
por: Döring, Yvonne, et al.
Publicado: (2014) -
Differential Estrogen-Regulation of CXCL12 Chemokine Receptors, CXCR4 and CXCR7, Contributes to the Growth Effect of Estrogens in Breast Cancer Cells
por: Boudot, Antoine, et al.
Publicado: (2011)